Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 51,629 | 41,358 | 21,790 | 16,249 | 6,890 |
| Cost of Goods | N/A | N/A | 0 | 0 | 14,376 |
| Gross Profit | 51,629 | 41,358 | 21,790 | 16,249 | -7,486 |
| Operating Expenses | 117,768 | 81,842 | 43,770 | 29,973 | 18,756 |
| Operating Income | -66,139 | -40,484 | -21,980 | -13,724 | -25,866 |
| Interest Expense | 12,138 | 2,075 | 270 | 66 | -57 |
| Other Income | -19,126 | 4,111 | 3,900 | 3,807 | 15,900 |
| Pre-tax Income | -97,403 | -38,448 | -18,350 | -9,983 | -9,909 |
| Net Income Continuous | -97,403 | -38,448 | -18,356 | -9,983 | -9,909 |
| Net Income | $-97,403 | $-38,448 | $-18,350 | $-9,983 | $-9,909 |
| EPS Basic Total Ops | -34.78 | -16.94 | -8.77 | -5.40 | -6.60 |
| EPS Basic Continuous Ops | -34.77 | -16.95 | -8.75 | -5.43 | -6.63 |
| EPS Diluted Total Ops | -34.78 | -16.94 | -8.77 | -5.40 | -6.60 |
| EPS Diluted Continuous Ops | -34.77 | -16.95 | -8.75 | -5.43 | -6.63 |
| EBITDA(a) | $-56,015 | $-33,291 | $-18,390 | $-11,286 | $-24,633 |